RPM

Analyst Upgrades: Top Wall Street analysts have upgraded several companies, including Colgate-Palmolive, Eaton Corporation, Lyell Immunopharma, RPM International, and Synopsys, with new price targets set for each.

Colgate-Palmolive Upgrade: RBC Capital upgraded Colgate-Palmolive from Sector Perform to Outperform with a price target of $88, while shares closed at $76.11.

Eaton Corporation Upgrade: Wolfe Research upgraded Eaton Corporation from Peer Perform to Outperform, setting a price target of $413, with shares closing at $343.39.

Lyell Immunopharma and RPM Upgrades: HC Wainwright upgraded Lyell Immunopharma from Neutral to Buy with a price target increase from $20 to $45, and RBC Capital upgraded RPM International from Sector Perform to Outperform with a new target of $132, up from $121.

Quarterly Performance: Compass Minerals reported a quarterly loss of $0.17 per share, slightly worse than the expected loss of $0.15, but improved from a loss of $0.77 per share a year ago. The company also posted revenues of $227.5 million, exceeding estimates by 1.69%.

Stock Outlook: Despite a significant year-to-date stock increase of 80.3%, the company's future performance is uncertain, with a current Zacks Rank of #3 (Hold), indicating expected performance in line with the market.

Earnings Estimates: The consensus EPS estimate for the upcoming quarter is $0.03 on revenues of $381.03 million, while the fiscal year estimate is $0.62 on $1.31 billion in revenues. The trend of earnings estimate revisions is mixed, which could impact stock performance.

Industry Context: The Chemical - Diversified industry, to which Compass belongs, is currently ranked in the bottom 13% of Zacks industries, suggesting that broader industry performance may significantly influence Compass's stock trajectory.